Transcriptional and bioinformatic analysis of GABA A receptors expressed in oligodendrocyte progenitor cells from the human brain

• Published in: Frontiers in molecular neuroscience 2023, Vol.16, p.1279232
• Main Authors: Gutierrez, Berenice A, González-Coronel, José Manuel, Arellano, Rogelio O, Limon, Agenor
• Format: Article
• Language: English
• ISSN: 1662-5099; 1662-5099

Oligodendrocyte progenitor cells (OPCs) are vital for neuronal myelination and remyelination in the central nervous system. While the molecular mechanisms involved in OPCs' differentiation and maturation are not completely understood, GABA is known to positively influence these processes through the activation of GABA receptors (GABA Rs). The molecular identity of GABA Rs expressed in human OPCs remains unknown, which restricts their specific pharmacological modulation to directly assess their role in oligodendrocytes' maturation and remyelination. In this study, we conducted a transcriptomic analysis to investigate the molecular stoichiometry of GABA Rs in OPCs from the human brain. Using eight available transcriptomic datasets from the human brain cortex of control individuals, we analyzed the mRNA expression of all 19 known GABA Rs subunit genes in OPCs, with variations observed across different ages. Our analysis indicated that the most expressed subunits in OPCs are α1-3, β1-3, γ1-3, and ε. Moreover, we determined that the combination of any α with β2 and γ2 is likely to form heteropentameric GABA Rs in OPCs. Importantly, we also found a strong correlation between GABA R subunits and transcripts for postsynaptic scaffold proteins, suggesting the potential postsynaptic clustering of GABA Rs in OPCs. This study presents the first transcriptional-level identification of GABA R subunits expressed in human OPCs, providing potential receptor combinations. Understanding the molecular composition of GABA Rs in OPCs not only enhances our knowledge of the underlying mechanisms in oligodendrocyte maturation but also opens avenues for targeted pharmacological interventions aimed at modulating these receptors to promote remyelination in neurological disorders.